Association Between Survivin Gene Promoter -31 C/G Polymorphism and Urothelial Carcinoma Risk in Taiwanese Population

Urology

Volumn 73, Issue 3, 2009, Pages 670-674

  Wang, Yuan Hung ^a   Chiou, Hung Yi ^a   Lin, Chang Te ^b   Hsieh, Hsiao Yen ^b   Wu, Chia Chang ^c   Hsu, Cheng Da ^b,d   Shen, Cheng Huang ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

SURVIVIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; TAIWAN; UROGENITAL TRACT TUMOR;

AGED; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; TAIWAN; UROLOGIC NEOPLASMS;

EID: 60549114512     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.09.048     Document Type: Article

References (29)

1. Melet A., Song K., Bucur O., et al. Apoptotic pathways in tumor progression and therapy. Adv Exp Med Biol 615 (2008) 47-79
2. Reed J.C. The survivin saga goes in vivo. J Clin Invest 108 (2001) 965-969
3. Sah N.K., Khan Z., Khan G.J., et al. Structural, functional and therapeutic biology of survivin. Cancer Lett 244 (2006) 164-171
4. Duffy M.J., O'Donovan N., Brennan D.J., et al. Survivin: a promising tumor biomarker. Cancer Lett 249 (2007) 49-60
5. Shen C.H., Wang Y.H., Wang W.C., et al. Inducible nitric oxide synthase promoter polymorphism, cigarette smoking, and urothelial carcinoma risk. Urology 69 (2007) 1001-1006
6. Samanic C., Kogevinas M., Dosemeci M., et al. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev 15 (2006) 1348-1354
7. Strope S.A., and Montie J.E. The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation. J Urol 180 (2008) 31-37
8. Karam J.A., Lotan Y., Ashfaq R., et al. Survivin expression in patients with non- muscle-invasive urothelial cell carcinoma of the bladder. Urology 70 (2007) 482-486
9. Ponnelle T., Chapusot C., Martin L., et al. Cellular localisation of survivin: impact on the prognosis in colorectal cancer. J Cancer Res Clin Oncol 131 (2005) 504-510
10. Ulukus E.C., Kargi H.A., Sis B., et al. Survivin expression in non-small-cell lung carcinomas: correlation with apoptosis and other apoptosis-related proteins, clinicopathologic prognostic factors and prognosis. Appl Immunohistochem Mol Morphol 15 (2007) 31-37
11. Lin C.Y., Hung H.C., Kuo R.C., et al. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan. Oral Oncol 41 (2005) 645-654
12. Smith S.D., Wheeler M.A., Plescia J., et al. Urine detection of survivin and diagnosis of bladder cancer. JAMA 285 (2001) 324-328
13. Shariat S.F., Casella R., Khoddami S.M., et al. Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer. J Urol 171 (2004) 626-630
14. Ku J.H., Kwak C., Lee H.S., et al. Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder. J Urol 171 (2004) 631-635
15. Chiou S.K., Jones M.K., and Tarnawski A.S. Survivin-an anti-apoptosis protein: its biological roles and implications for cancer and beyond. Med Sci Monit 9 (2003) PI25-PI29
16. Li F., Ambrosini G., Chu E.Y., et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396 (1998) 580-584
17. Pasin E., Josephson D.Y., Mitra A.P., et al. Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history. Rev Urol 10 (2008) 31-43
18. Chiu B.C., Lynch C.F., Cerhan J.R., et al. Cigarette smoking and risk of bladder, pancreas, kidney, and colorectal cancers in Iowa. Ann Epidemiol 11 (2001) 28-37
19. Wittke-Thompson J.K., Pluzhnikov A., and Cox N.J. Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet 76 (2005) 967-986
20. Borbély A.A., Murvai M., Szarka K., et al. Survivin promoter polymorphism and cervical carcinogenesis. J Clin Pathol 60 (2007) 303-306
21. Jang J.S., Kim K.M., Kang K.H., et al. Polymorphisms in the survivin gene and the risk of lung cancer. Lung Cancer 60 (2008) 31-39
22. Cheng Z.J., Hu L.H., and Huang S.J. Correlation of -31 G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma. Ai Zheng 27 (2008) 258-263
23. Xu Y., Fang F., Ludewig G., et al. A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol 23 (2004) 527-537
24. Zeidler R., Albermann K., and Lang S. Nicotine and apoptosis. Apoptosis 12 (2007) 1927-1943
25. Dasgupta P., Kinkade R., Joshi B., et al. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci USA 103 (2006) 6332-6337
26. Pina-Cabral L., Santos L., Mesquita B., et al. Detection of survivin mRNA in urine of patients with superficial urothelial cell carcinomas. Clin Transl Oncol 9 (2007) 731-736
27. Schultz I.J., Kiemeney L.A., Witjes J.A., et al. Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence. Anticancer Res 23 (2003) 3327-3331
28. Ohsawa I., Nishimura T., Kondo Y., et al. Detection of urine survivin in 40 patients with bladder cancer. J Nippon Med Sch 71 (2004) 379-383
29. Wang H., Xi X., Kong X., et al. The expression and significance of survivin mRNA in urinary bladder carcinomas. J Cancer Res Clin Oncol 130 (2004) 487-490